C. Gunnarsson

发表

Hereditary Hypertrophic Cardiomyopathy in Children and Young Adults—The Value of Reevaluating and Expanding Gene Panel Analyses

H. Gréen, J. Karlsson, E. Fernlund, 2020, Genes.

Hypersecretion of ovarian androgens may be gonadotrophin dependent many years after menopause.

M. Hammar, C. Gunnarsson, Anna Jakobsson, 2000, Maturitas.

The congenital disorder of glycosylation in PGM1 (PGM1-CDG) can cause severe cardiomyopathy and unexpected sudden cardiac death in childhood.

H. Gréen, E. Fernlund, Rada Ellegård, 2019, Forensic science international. Genetics.

Novel Genetic Variants in BAG3 and TNNT2 in a Swedish Family with a History of Dilated Cardiomyopathy and Sudden Cardiac Death

M. Gustafsson, E. Kuchinskaya, E. Fernlund, 2017, Pediatric Cardiology.

Proliferative responses to altered 17beta-hydroxysteroid dehydrogenase (17HSD) type 2 expression in human breast cancer cells are dependent on endogenous expression of 17HSD type 1 and the oestradiol receptors.

O. Stål, C. Gunnarsson, A. Jansson, 2006, Endocrine-related cancer.

17β-Hydroxysteroid dehydrogenases involved in local oestrogen synthesis have prognostic significance in breast cancer

O. Stål, T. B. C. Group, C. Gunnarsson, 2005, British Journal of Cancer.

Amplification of HSD17B1 and ERBB2 in primary breast cancer

K. Kirschner, L. Skoog, O. Stål, 2003, Oncogene.

Ratio of 17HSD1 to 17HSD2 Protein Expression Predicts the Outcome of Tamoxifen Treatment in Postmenopausal Breast Cancer Patients

L. Skoog, O. Stål, B. Nordenskjöld, 2009, Clinical Cancer Research.

in Breast Cancer Predicts Late Recurrence -Hydroxysteroid Dehydrogenases β Abnormal Expression of 17

O. Stål, C. Gunnarsson, B. Olsson, 2013 .

Abnormal expression of 17beta-hydroxysteroid dehydrogenases in breast cancer predicts late recurrence.

O. Stål, C. Gunnarsson, B. Olsson, 2001, Cancer research.

Abnormal Expression of 17-Hydroxysteroid Dehydrogenases in Breast Cancer Predicts Late Recurrence 1

O. Stål, C. Gunnarsson, B. Olsson, 2001 .

High ECG Risk-Scores Predict Late Gadolinium Enhancement on Magnetic Resonance Imaging in HCM in the Young

H. Gréen, E. Fernlund, C. Gunnarsson, 2021, Pediatric Cardiology.

Monozygotic twins with myocarditis and a novel likely pathogenic desmoplakin gene variant

H. Gréen, J. Karlsson, E. Fernlund, 2020, ESC heart failure.

Assessment of HaloPlex amplification for sequence capture and massively parallel sequencing of arrhythmogenic right ventricular cardiomyopathy-associated genes.

H. Gréen, J. Jonasson, C. Gunnarsson, 2015, The Journal of molecular diagnostics : JMD.

Homozygous missense MYBPC3 Pro873His mutation associated with increased risk for heart failure development in hypertrophic cardiomyopathy

J. Karlsson, Antheia Kissopoulou, J. Jonasson, 2018, ESC heart failure.

Amplification of HSD17B1 has prognostic significance in postmenopausal breast cancer

O. Stål, B. Nordenskjöld, C. Gunnarsson, 2008, Breast Cancer Research and Treatment.

Novel plakophilin2 mutation: Three-generation family with arrhythmogenic right ventricular cardiomyopathy

J. Engvall, P. Söderkvist, E. Nylander, 2012, Scandinavian cardiovascular journal : SCJ.

Whole exome sequencing of FFPE samples—expanding the horizon of forensic molecular autopsies

Emma Adolfsson, J. Jonasson, C. Gunnarsson, 2022, International Journal of Legal Medicine.

Molecular characterization and clinical features of a patient with an interstitial deletion of 3p25.3‐p26.1

C. Gunnarsson, C. Foyn Bruun, 2010, American journal of medical genetics. Part A.

Macrophage traits in cancer cells are induced by macrophage-cancer cell fusion and cannot be explained by cellular interaction

P. Wegman, C. Gunnarsson, I. Shabo, 2015, BMC Cancer.

Bent Spine Syndrome: A Phenotype of Dysferlinopathy or a Symptomatic DYSF Gene Mutation Carrier

A. Landtblom, C. Gunnarsson, M. Vrethem, 2012, European Neurology.

17β-Hydroxysteroid Dehydrogenase 14 Affects Estradiol Levels in Breast Cancer Cells and Is a Prognostic Marker in Estrogen Receptor–Positive Breast Cancer

O. Stål, C. Gunnarsson, A. Jansson, 2006 .

Methods for evaluating HER2 status in breast cancer: comparison of IHC, FISH, and real-time PCR analysis of formalin-fixed paraffin-embedded tissue

C. Gunnarsson, H. Olsson, A. Jansson, 2013 .

Activating Mutations Affecting the Dbl Homology Domain of SOS2 Cause Noonan Syndrome

Trevor J Pugh, L. Pennacchio, J. Priest, 2015, Human mutation.

A new polymorphism in the coding region of exon four in HSD17B2 in relation to risk of sporadic and hereditary breast cancer

B. Persson, A. Lindblom, S. Margolin, 2007, Breast Cancer Research and Treatment.

Expression of COX-2 and steroid converting enzymes in breast cancer.

L. Skoog, O. Stål, L. Ferraud, 2006, Oncology reports.

Methods for evaluating HER 2 status in breast cancer : comparison of IHC , FISH , and real-time PCR analysis of formalin-fixed paraffin-embedded tissue

C. Gunnarsson, H. Olsson, A. Jansson, 2013 .

Chromosome r(10)(p15.3q26.12) in a newborn child: case report

J. Jonasson, C. Gunnarsson, B. Graffmann, 2009, Molecular Cytogenetics.

Definition and clinical variability of SHANK3-related Phelan-McDermid syndrome.

T. Bourgeron, R. Hennekam, C. V. van Ravenswaaij-Arts, 2023, European journal of medical genetics.

Novel L1CAM splice site mutation in a young male with L1 syndrome

J. Jonasson, C. Gunnarsson, Malin Rehnberg, 2011, American journal of medical genetics. Part A.

Genetic Variant Score and Arrhythmogenic Right Ventricular Cardiomyopathy Phenotype in Plakophilin-2 Mutation Carriers

J. Svendsen, W. Zareba, T. Edvardsen, 2021, Cardiology.

17β-Hydroxysteroid Dehydrogenase Type 14 Is a Predictive Marker for Tamoxifen Response in Oestrogen Receptor Positive Breast Cancer

L. Skoog, O. Stål, B. Nordenskjöld, 2012, PloS one.

Arrhythmogenic Right Ventricular Cardiomyopathy - 4 Swedish families with an associated PKP2 c.2146-1G>C variant.

C. Gunnarsson, A. Gréen, A. Svensson, 2016, American journal of cardiovascular disease.

Novel SMAD3 p.Arg386Thr genetic variant co‐segregating with thoracic aortic aneurysm and dissection

J. Jonasson, C. Gunnarsson, F. Vánky, 2020, Molecular genetics & genomic medicine.

Technical in-depth comparison of two massive parallel DNA-sequencing methods for formalin-fixed paraffin-embedded tissue from victims of sudden cardiac death.

Emma Adolfsson, H. Gréen, J. Jonasson, 2021, Forensic science international. Genetics.

The frequency of anti‐C + anti‐G in the absence of anti‐D in alloimmunized pregnancies

M. Palfi, C. Gunnarsson, C. Gunnarsson, 2001, Transfusion medicine.

Case report: KPTN gene-related syndrome associated with a spectrum of neurodevelopmental anomalies including severe epilepsy

A. Kaindl, S. Biskup, C. Gunnarsson, 2023, Frontiers in Neurology.

Gustavson syndrome is caused by an in-frame deletion in RBMX associated with potentially disturbed SH3 domain interactions.

A. Ameur, M. Vihinen, A. Nordgren, 2023, European journal of human genetics : EJHG.

17β-Hydroxysteroid Dehydrogenase Type 14 Is a Predictive Marker for Tamoxifen Response in Oestrogen Receptor Positive Breast Cancer

L. Skoog, O. Stål, B. Nordenskjöld, 2012, PLoS ONE.

Bent Spine Syndrome: A Phenotype of Dysferlinopathy or a Symptomatic DYSF Gene Mutation Carrier

A. Landtblom, C. Gunnarsson, M. Vrethem, 2012, European Neurology.

17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer.

O. Stål, C. Gunnarsson, Maja Cohen, 2006, Cancer research.